Tiziana Life Sciences is trading at $1.42 (up 6.8%) as the stock extends a multi-day rebound following sharp losses earlier in July.

  • The move appears to be follow-through buying after a roughly 10% rise on July 13, supported by broader risk-on sentiment in U.S. equities.
  • There have been no fresh company-specific news developments or analyst actions reported on July 14 to serve as a new fundamental catalyst.